Asenapine
Abstract
In August 2009, asenapine (Saphris; Schering-Plough) was approved by the US FDA for the acute treatment of schizophrenia and manic or mixed episodes associated with bipolar I disorder in adults.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
